Taj Pharma India

Welcome to the Taj Pharmaceuticals Limited India site. We would like to give you an overview of Taj Pharmaceuticals Limited in India: our background, organization, products, core belief and prospects.

We at Taj Pharmaceuticals Limited India are committed to our customers and employees and, more importantly, to the people who rely on our medicines. We plan to move forward with greater vigour and a clearer vision to put each and every individual at the heart of our commitment, working for healthier India – health. With the creation of Taj Pharmaceuticals Limited, we now have access to one of the richest and most innovative research pipelines in the pharmaceutical industry. We're building on our history of hard work, diligence and success, by working tirelessly to enhance the value we are committed to provide towards improving health and the quality of lives across the world.



Quality has always been a strong part of Taj Pharmaceuticals proposition. Care is taken to ensure a high level of quality in our products and services.

Life - It is the underlying purpose of everything we do at Taj pharmaceuticals Ltd. We are committed to developing a distinguished branded pharmaceuticals business. A purpose that defines our R & D strategy of discovering & developing innovative products that improve the quality of life. we are one of the fast growing company in India & abroad. We manufacture various types of medicines that includes-: Diabetic care products, Insulin, Delivery system, Growth hormones, Food and Nutraceuticals, All types of Surgical equipments & Life Saving drugs. We also leads emphasis to all types of country drugs like- Ayurvedic, Herbal Products, etc. Here you will find complete solution for regular health & personal care, body care & skin care requirements. Our key focus areas for growth include major Therapeutic Segments like Cardiovascular, CNS, Cancer, Aids, inflammatory & Ophthalmology. Having defined a branded products portfolio, We are actively looking for Marketing Firms/ Distributors / Agents with complimentary skills, People who can extend the reach of our brands & / or for whom we can extend the reach of their brands. Quality has always been a strong part of Taj Pharmaceuticals proposition. Care is taken to ensure a high level of quality in our products and services.

For more information visit by Taj Pharma Group India.

Click here for Download pdf of patient information
Click here for Download pdf of prescribing information

Our services

About Taj Pharma

Welcome to the Taj Pharmaceuticals Limited India site. We would like to give you an overview of Taj Pharmaceuticals Limited in India: our background, organization, products, core belief and prospects.

Customer Faq's

This section displays common questions about the Vincristine Sulfate for Injection.

Product Glimpse

Vincristine is a chemotherapy drug that belongs to a group of drugs called vinca alkaloids. Vincristine works by stopping the cancer cells from separating into 2 new cells. So, it stops the growth of the cancer.

Contact Taj

214, Bake House, Bake House Lane,
Fort, Mumbai 400001, India.

Download Leaflet

Patient Leaflet

Click here for Download pdf of patient information

Prescribing Leaflet

Click here for Download pdf of prescribing information

Other Generic Products

A dream for new world Anchored in India and committed to its traditional values of leadership with trust, the Taj Pharma Group is spreading its footprint globally through excellence and innovation. Taj Pahrma

doctor

Venoxtaj

doctor

Defrataj

doctor

Cefozone

doctor

Tacrotaj

Important Safety Information

“This preparation is for intravenous use only. It should be administered by individuals experienced in the administration of vincristine sulfate injection. The intrathecal administration of vincristine sulfate injection (vincristine sulfate) usually results in death. Syringes containing this product should be labeled, using the auxiliary sticker provided, to state “FATAL IF GIVEN INTRATHECALLY. FOR INTRAVENOUS USE ONLY.”
"Extemporaneously prepared syringes containing this product must be packaged in an overwrap which is labeled “DO NOT REMOVE COVERING UNTIL MOMENT OF INJECTION. FATAL IF GIVEN INTRATHECALLY. FOR INTRAVENOUS USE ONLY.”"
"Treatment of patients following intrathecal administration of vincristine sulfate injection has included immediate removal of spinal fluid and flushing with Lactated Ringer's, as well as other solutions and has not prevented ascending paralysis and death. In one case, progressive paralysis in an adult was arrested by the following treatment initiated immediately after the intrathecal injection:"
"1. As much spinal fluid was removed as could be safely done through lumbar access."
"2. The subarachnoid space was flushed with Lactated Ringer's solution infused continuously through a catheter in a cerebral lateral ventricle at the rate of 150 mL/h. The fluid was removed through a lumbar access."
"3. As soon as fresh frozen plasma became available, the fresh frozen plasma, 25 mL, diluted in 1 L of Lactated Ringer's solution was infused through the cerebral ventricular catheter at the rate of 75 mL/h with removal through the lumbar access. The rate of infusion was adjusted to maintain a protein level in the spinal fluid of 150 mg/dL."
"4. Glutamic acid, 10 g, was given intravenously over 24 hours followed by 500 mg 3 times daily by mouth for 1 month or until neurological dysfunction stabilized. The role of glutamic acid in this treatment is not certain and may not be essential."
"Pregnancy Category D - Vincristine sulfate can cause fetal harm when administered to a pregnant woman. When pregnant mice and hamsters were given doses of vincristine sulfate that caused resorption of 23% to 85% of fetuses, fetal malformations were produced in those that survived. Five monkeys were given single doses of vincristine sulfate between days 27 and 34 of their pregnancies; 3 of the fetuses were normal at term, and 2 viable fetuses had grossly evident malformations at term. In several animal species, vincristine sulfate can induce teratogenesis as well as embryo death at doses that are nontoxic to the pregnant animal. There are no adequate and well-controlled studies in pregnant women. If this drug is used during pregnancy or if the patient becomes pregnant while receiving this drug, she should be apprised of the potential hazard to the fetus. Women of child-bearing potential should be advised to avoid becoming pregnant."